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Abstract
Introduction In 2006, our provincial government initi-
ated a program to reduce wait times for total hip or knee
replacements by referring patients to a single tertiary-care
centre. This program provided an opportunity to identify
risk factors for perioperative complications as part of a
continuing quality improvement project. We report the risk
of postoperative urinary retention after hip and knee
replacements and the risk factors associated with this
complication.
Methods After local Research Ethics Board approval,
data were abstracted from charts of patients who under-
went elective primary unilateral total hip or knee
replacement surgery. The outcome was urinary retention in
the ﬁrst 24 hr after surgery. Risk factors were identiﬁed
using multivariable logistic regression, and they were
expressed as odds ratios (OR) or 95% conﬁdence intervals
(CI).
Results From April 1, 2006 to May 31, 2007, 1,440
patients underwent 1,515 elective total hip replacement or
total knee replacement. We abstracted data from 1,031
(71.3%) patients: mean age, 62 yr (interquartile range
[IQR] 55-70); 53.7% female; 605 total hip replacements;
and 426 total knee replacements. The procedures were
performed under spinal (81.8%), general (10.2%), or
combined spinal and general (8.0%) anesthesia. Patients
spent 100 [IQR 90-114] min in the operating room and 3
[IQR 3-4] days in hospital. The 24-hr incidence of urinary
retention was 43.3% (446/1031). Male sex (odds ratio
[OR] 3.9; 95% CI 3.0 to 5.2), total hip replacement (OR
1.4; 95% CI 1.1 to 1.9), and intrathecal morphine were risk
factors.
Discussion Postoperative urinary retention is a common
complication after total hip or total knee replacement,
especially amongst men and patients receiving intrathecal
morphine.
Re ´sume ´
Introduction En 2006, notre gouvernement provincial a
lance ´ un programme aﬁn de re ´duire les temps d’attente
pour les arthroplasties totales de la hanche ou du genou en
re ´fe ´rant les patients a ` un seul centre de soins tertiaires. Ce
programme a e ´te ´ l’occasion d’identiﬁer les facteurs de
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d’un projet d’ame ´lioration continue de la qualite ´. Nous
rapportons ici le risque de re ´tention urinaire postope ´ratoire
apre `s une arthroplastie de la hanche ou du genou et les
facteurs de risque associe ´sa ` cette complication.
Me ´thode Apre `s avoir obtenu l’approbation du comite ´
d’e ´thique de la recherche local, les donne ´es ont e ´te ´
extraites des dossiers des patients ayant subi une
arthroplastie totale unilate ´rale primaire et non urgente de
la hanche ou du genou. Le crite `re d’e ´valuation e ´tait la
re ´tention urinaire au cours des 24 premie `res heures
postope ´ratoires. Les facteurs de risque ont e ´te ´ identiﬁe ´sa `
l’aide d’une analyse par re ´gression logistique multivarie ´e
et ont e ´te ´ exprime ´s en rapports de cotes [RC] (intervalles
de conﬁance [IC] 95 %).
Re ´sultats Entre le 1
er avril 2006 et le 31 mai 2007, 1440
patients ont subi 1515 arthroplasties totales non urgentes
de la hanche ou du genou. Nous avons extrait les donne ´es
de 1031 (71,3 %) patients [a ˆge 62 ans (e ´cart interquartile
[EIQ] 55-70); 53,7 % de femmes; 605 arthroplasties
totales de la hanche, 426 arthroplasties totales du genou].
Les interventions ont e ´te ´ re ´alise ´es sous rachianesthe ´sie
(81,8 %), anesthe ´sie ge ´ne ´rale (10,2 %), ou rachianesthe ´sie
et anesthe ´sie ge ´ne ´rale combine ´es (8,0 %). Les patients
ont passe ´ 100 (EIQ 90-114) min en salle d’ope ´ration et 3
(EIQ 3-4) jours a ` l’ho ˆpital. L’incidence a ` 24 h de re ´tention
urinaire e ´tait de 43,3 % (446/1031). Le sexe masculin
(rapport de cotes [RC] 3,9; IC 95 % 3,0 a ` 5,2),
l’arthroplastie totale de la hanche (RC 1,4, IC 95 % 1,1 a `
1,9) et la morphine intrathe ´cale ont constitue ´ des facteurs
de risque.
Discussion La re ´tention urinaire postope ´ratoire est une
complication courante apre `s une arthroplastie totale de la
hanche ou du genou, particulie `rement chez les hommes et
les patients recevant de la morphine intrathe ´cale.
Hip and knee arthroplasties are increasingly common
procedures with 62,196 procedures performed in Canada
(excluding Quebec) from 2006 to 2007. This total is a
101% increase over the prior decade and a 6% increase
over the prior year.
1 Spinal anesthesia is a common choice
of anesthesia for these procedures,
A which are often per-
formed on elderly patients with comorbid conditions.
The risk for urinary retention after hip or knee arthro-
plasty has varied widely amongst different reports
depending on the anesthesia and analgesia with estimates
ranging from 0 to 75%.
2 In one recent review, the authors
estimated the pooled weighted mean incidence to be as low
as 8.8% (95% conﬁdence interval [CI] 5.2 to 12.4) for
continuous peripheral nerve blockade to as high as 34.1%
(95% CI 32.9 to 35.4) for epidural analgesia.
2 Postopera-
tive urinary retention can lead to signiﬁcant morbidity,
such as prosthetic infection and sepsis.
2 Urinary retention
following spinal anesthesia for hip or knee arthroplasty is
well documented, but estimates of risks are based on small
samples and vary widely amongst reports.
2 Similarly,
identiﬁcation of risk factors for urinary retention in this
population has resulted in discrepant conclusions.
2
The opening of the Centre for Surgical Innovation (CSI),
an initiative to reduce wait times for hip and knee arthro-
plasties in the province of British Columbia (BC), Canada,
provided us the opportunity to study a large homogeneous
group of patients who underwent hip or knee arthroplasties
under similar anesthetics. The purposes of this study were
to estimate the 24-hr risk of postoperative urinary retention
in a cohort of patients undergoing primary elective uni-
lateral total hip or total knee arthroplasty and to identify
risk factors for postoperative urinary retention in the same
cohort.
Methods
This article on our single-centre cohort study is reported
in accordance with the STrengthening the Reporting
of OBservational studies in Epidemiology (STROBE)
guidelines.
3,4
Study setting and participants
In February 2006, the BC provincial government and the
Vancouver Coastal Health Authority established the Uni-
versity of BC Hospital (Vancouver Acute) Centre for
Surgical Innovation (CSI) and implemented the Osteoar-
thritis Service Integration System (OASIS) Program to
reduce the wait times for elective major joint reconstructive
surgery. The University of BC Hospital is a tertiary-referral
centre in Vancouver, BC afﬁliated with the University of
BC. The CSI focuses on elective primary total hip and knee
replacement procedures. Patients requiring joint replace-
ment from acute trauma, such as hip fractures, are
ineligible. Participating orthopedic surgeons from all over
the province identify and schedule eligible patients for
surgery at the Centre. To avoid delays and cancellations, all
CSI patients are evaluated at the Vancouver Acute anes-
thesia consult clinic at least 24 hr prior to surgery. The ﬁrst
hip and knee replacement procedures were performed on
April 1, 2006.
Although the anesthetics were not standardized, they
were similar amongst the members of the department.
For general anesthesia, induction was achieved with
A Available at http://www.postoppain.org/content.aspx?nid=57632
and http://www.postoppain.org/image.aspx?imgid=654 (Both acces-
sed 24 March 2010).
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123intravenous fentanyl, propofol, and rocuronium. Anesthesia
was maintained using sevoﬂurane or desﬂurane with
rocuronium and long-acting intravenous opioids (morphine
or hydromorphone) administered as needed. In some cases,
an intravenous propofol infusion was added. For spinal
anesthesia, neuraxial blockade was achieved using intra-
thecal long-acting local anesthetic (bupivacaine or
ropivacaine) with intrathecal morphine added at the dis-
cretion of the attending anesthesiologist. All patients
received cefazolin 2 g iv (or clindamycin 600 mg iv if
penicillin allergy was documented) prior to surgical inci-
sion. Intravenous ﬂuid therapy consisted of crystalloids
(normal saline or Plasmalyte) only. All patients received
oral oxycodone and patient-controlled analgesia with
intravenous morphine or hydromorphone in the postoper-
ative period. Physiotherapy and nursing care followed a
clinical pathway to promote consistency of care. With
regard to voiding, the nursing policy was to avoid routine
intraoperative or postoperative catheterization of the
patient’s bladder due to concerns of infection.
As this was a retrospective study using patient records,
the UBC Clinical Research Ethics Board waived the
requirement for informed consent when it granted
approval. After approval for access of information from the
Vancouver Coastal Health Authority, hospital records of
patients who were admitted to the CSI for primary hip or
knee unilateral replacement procedures from April 1, 2006
to May 31, 2007 were identiﬁed through the Operating
Room Management Information System (ORMIS) using
the Vancouver Coastal Health procedure codes for primary
hip and knee replacement procedures. Patients were
included in this study if they met the Centre’s admission
criteria: age 14 to 80 yr, American Society of Anesthesi-
ologists’ (ASA) physical status class I-III, body mass index
\40 kgm
-2, pre-assessment 24-hr opiate consumption
B60 mg oral morphine, consent given to receive blood
transfusions, and absence of coagulation disorders or
obstructive sleep apnea-hypopnea (based on overnight
oximetry or polysomnography). Patients were excluded
from this study if they had a history of chronic urinary
retention (e.g., neurogenic bladder); they were admitted to
the CSI but did not receive an anesthetic and undergo
surgery (i.e., cancellation of case), or they received an
indwelling bladder catheter intraoperatively. For patients
who underwent more than one operation (on separate
admissions) at the CSI, we used the data from the ﬁrst
admission only.
As we did not have a prior estimate of the rate of urinary
retention in the population of interest at our Centre, our
initial plan was to sample all eligible patients. After
abstracting data from the records of 100 patients, we
determined that all eligible patients were not necessary to
achieve an adequate sample size (see below), and a random
sample was chosen to save time and money. The order in
which the paper records were sampled was randomized by
the Health Record staff who held the master list of all
eligible patients.
We abstracted data from individual patient paper records
and entered our data directly into a Microsoft Excel
TM
spreadsheet. The spreadsheet included a data dictionary
deﬁning each variable and a guide to the source document
where the variable could be located in the hospital record.
To ensure consistency, each data abstractor (J.N., D.D.,
J.J.) underwent a training period wherein they and the
senior investigator (P.T.C.) abstracted data independently
from at least ten health records. When each data abstractor
achieved 100% agreement with the senior investigator, s/he
proceeded to abstract data independently. In addition, we
conducted weekly internal consistency checks of the data
tables to ﬂag potential discrepancies or errors (e.g., coding
‘‘yes’’ for intrathecal morphine and coding ‘‘0 lg’’ for its
dose) during the data collection period.
Variables
We abstracted data on variables related to demographics,
comorbid conditions, preoperative medications, surgical
and anesthetic details, surgical and anesthetic staff, times,
and postoperative complications (including nausea, vom-
iting, pruritis, urinary retention in the ﬁrst 24 hr after
surgery, and postoperative pain during hospital admission).
Values for variables derived from other variables (e.g.,
body mass index, durations) were calculated using formu-
lae in the spreadsheet. Opioid dosages were recorded as
equivalents in milligrams of morphine for each route of
administration.
Study outcome
The outcome for this analysis was urinary retention in the
ﬁrst 24 hr after surgery. The diagnostic criterion for urinary
retention was postoperative urinary (intermittent or
indwelling) catheterization due to 1) documented symp-
toms related to an inability to void after surgery or 2)
postoperative urinary retention identiﬁed by bladder
ultrasonography.
Sample size
Our initial goal was to collect data from all patients
meeting our selection criteria in the population of interest.
After data had been collected on the ﬁrst 100 patients, the
estimated 24-hr risk of urinary retention was 42% (95% CI
32.8 to 52.8). The estimated 24-hr risk of urinary retention
was 60% (21/35; 95% CI 43.6 to 74.5) in men and 32%
(21/65; 95% CI 22.2 to 44.4) in women. Since the purpose
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123of this study was to determine risk factors for urinary
retention, we designed our sample size in order to assure
stability around point estimates in a multivariable model,
even when examining for subgroup effects (e.g., sex).
Assuming 30% risk of urinary retention in females, with
twelve covariates to be used in the ﬁnal multivariable
model (including interaction covariates) and using ten
covariates per outcome as recommended by Peduzzi et al.,
5
approximately 400 female patients would be required.
Allowing for incomplete outcome and predictor ascertain-
ment, we estimated that 1,000 patients would be sufﬁcient
for the number of variables to be included in a multivari-
able analysis. The precision of the point estimate (based on
the 95% CI half-width) would range from 2.8% (for an
incidence of 30%) to 3.1% (for an incidence of 50%) with
1,000 patients.
Statistical analyses
We used Stata release 10 (StataCorp, TX, USA) to analyze
our data. We described categorical data, normally distrib-
uted data, and non-normally distributed data using
proportions (percent), mean (standard deviation [SD]), and
median (interquartile range [IQR]), respectively. Bivariate
analysis of categorical and continuous data was performed
using Chi square and two-sample Student’s t tests,
respectively. For the dosage of intrathecal morphine, we
collapsed the continuous data into four strata (none,
B100 lg, 101 to 150 lg, and [150 lg). Similarly, we
collapsed the data on intrathecal long-acting local anes-
thetic dosage into four strata (none, B10 mg, 10.1 to
12.5 mg, and[12.5 mg). Multivariable logistic regression
was used to model the association between postoperative
urinary retention and independent variables. Independent
variables were chosen a priori based on their potential
association with the outcome variable reported in prior
studies. These variables were: procedure (total hip vs total
knee arthroplasty), age (yr), male sex, dose of intrathecal
long-acting local anesthetic (as an ordinal variable), and
dose of intrathecal long-acting morphine. The dose of long-
acting intrathecal morphine was inserted as an indicator
variable with the referent category being general anesthesia
and the indicators being: spinal anesthesia without mor-
phine, B100 lg, 101 to 150 lg, and [150 lg. Fractional
polynomials were used to ensure the best functional form
of the continuous variable ‘‘age’’. Finally, we assessed for
effect measure modiﬁcation of sex by dose of intrathecal
morphine by introducing interaction terms into the ﬁnal
model. A complete-case analysis was performed. All tests
were two-sided and we considered a P value\0.05 level to
be statistically signiﬁcant.
Results
From April 1, 2006 to May 31, 2007, 1,440 patients
underwent 1,515 total hip or total knee arthroplasties.
During this period, 1,366 patients, 73 patients, and one
patient underwent one, two, and three major lower limb
arthroplasties, respectively. By the time all data abstractors
were notiﬁed that the sample size (1,000 patients) had been
reached, we had abstracted data relating to the ﬁrst pro-
cedure performed on 1,031 (71.3%) randomly sampled
subjects of the 1,440 patients. The ﬂow diagram for this
study is shown in Fig. 1.
The mean age of the 1,031 patients was 61.8 (10.8) yr;
477 (46.3%) were men. The preoperative patient charac-
teristics by postoperative urinary status are described in
Table 1. Of the 1,031 patients, 605 (58.7%) underwent
total hip arthroplasties and 426 (41.3%) underwent total
knee arthroplasties. Procedures were performed under
spinal anesthesia (n = 844, 81.8%), general anesthesia
(n = 105, 10.2%), or combined spinal and general anes-
thesia (n = 82, 8.0%). Patients spent 100 (IQR [90-114])
min in the operating room, 128 [96-165] min in the
recovery room, and three [3-4] days in hospital. The
Fig. 1 Flow diagram of subjects studied
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123operative and anesthetic characteristics by postoperative
urinary status are described in Table 2.
The overall 24-hr risk of postoperative urinary retention
was 43.3% (446/1031; 95% CI 40.3 to 46.3). The risk was
60.4% (288/477; 95% CI 55.9 to 64.7) amongst men and
28.5% (158/554; 95% CI 24.9 to 32.4) amongst women. On
bivariate analysis, statistically signiﬁcant differences (all
P\0.001 unless noted) were observed for male sex, ASA
physical status (P = 0.04), type of procedure, type of
anesthetic, dose of intrathecal local anesthetic, and dose of
intrathecal morphine (Tables 1 and 2). The ﬁnal unadjusted
and adjusted multivariable logistic regression models are
presented in Table 3. The ﬁnal multivariable model
included 435 outcome events in 1,006 patients. Both male
sex and total hip arthroplasty (compared with total knee
arthroplasty) were associated with increased odds of post-
operative urinary retention. Compared with general
anesthesia alone, any intrathecal morphine administration
was associated with increased odds of postoperative
urinary retention. We did not identify a dose-response
relationship when we examined only those patients
who received any intrathecal morphine (test-for-trend
P = 0.07).
As stated in the previous section, there was effect
measure modiﬁcation on dose of intrathecal morphine by
sex (interaction P\0.001). These results are presented in
Fig. 2. For males, there was a strong relationship between
presence of intrathecal morphine and the odds of postop-
erative urinary retention that was not present for females.
Compared with general anesthesia alone, males receiving
spinal anesthesia with morphine had a 7.1 to 12.2-fold
increased odds of postoperative urinary retention. Once
again, we did not see a dose-response relationship (test-for-
trend P = 0.13). For both males and females, spinal
anesthesia without morphine was not associated with
postoperative urinary retention.
Discussion
In this single tertiary centre cohort study, the 24-hr risk of
postoperative urinary retention after elective primary
Table 1 Preoperative patient characteristics by status of postopera-
tive urinary retention
Urinary
retention
(n = 446)
No urinary
retention
(n = 585)
P value
Age (yr), mean (SD) 61.3 (10.5) 62.2 (10.7) 0.20
Male sex, n (%) 288 (64.6) 189 (32.3) \0.001
Body mass index (kgm
-2),
mean (SD)
28.8 (5.4) 29.3 (5.3) 0.14
ASA classiﬁcation, n (%) 0.04
I 84 (18.8) 78 (13.3)
II 347 (77.8) 479 (81.9)
III 15 (3.4) 28 (4.8)
Smoking status, n (%) 0.90
Non-smoker 325 (72.9) 434 (74.2)
Ex-smoker 85 (19.1) 99 (16.9)
Current smoker 36 (8.1) 52 (8.9)
Preoperative opioid use, n (%) 45 (10.1) 70 (12.0) 0.90
Preoperative beta blocker use,
n (%)
28 (6.3) 53 (9.1) 0.10
ASA = American Society of Anesthesiologists; SD = standard
deviation
Table 2 Operative and anesthetic characteristics by status of post-
operative urinary retention
Urinary
retention
(n = 446)
No urinary
retention
(n = 585)
P value
Procedure, n (%) \0.001
Total knee arthroplasty 157 (35.2) 269 (46.0)
Total hip arthroplasty 289 (64.8) 316 (54.0)
Oral opioid
postoperatively, n (%)
87 (19.5) 104 (17.8) 0.40
Type of anesthesia, n (%) \0.001
General anesthesia 23 (5.2) 82 (14.2)
General and spinal
anesthesia
41 (9.2) 40 (6.8)
Spinal anesthesia 382 (85.7) 462 (79.0)
Missing 0 1 (0.2)
Intrathecal local
anesthesia* dose, n (%)
\0.001
General anesthesia only 23 (5.2) 82 (14.2)
B10 mg 94 (21.1) 161 (27.5)
10.1–12.5 mg 190 (42.6) 224 (38.3)
[12.5 mg 128 (28.7) 105 (18.0)
Missing 11 (2.5) 13 (2.2)
Intrathecal morphine
dose, n (%)
\0.001
General anesthesia only 23 (5.2) 82 (14.0)
Spinal anesthesia without
morphine
42 (9.4) 109 (18.6)
B100 lg 253 (56.7) 287 (49.1)
101–150 lg 89 (20.0) 65 (11.1)
[150 lg 37 (8.3) 34 (5.8)
Missing 2 (0.5) 8 (1.4)
Median minutes in
operating room [IQR]
101 [90–115] 100 [90–113] 0.26
Median minutes in
recovery room [IQR]
130 [98–165] 125 [95–165] 0.48
Median days of hospital
stay [IQR]
3 [3–4] 3 [3–4] 0.62
* Bupivacaine or ropivacaine; IQR = interquartile range
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(95% CI 40.3 to 46.3). Male sex, total hip arthroplasty, and
the presence of any dose of intrathecal morphine were
associated with this complication. Furthermore, the
increased risk of postoperative urinary retention with
intrathecal morphine appeared to be conﬁned primarily to
males, as evident from signiﬁcant effect measure modiﬁ-
cation in our cohort.
Our results are consistent with the results from many
prior studies. However, as with all observational studies,
Table 3 Multivariable logistic
regression analysis of factors
that are related to postoperative
urinary retention
CI = conﬁdence interval;
ORadj = adjusted odds ratio;
ORunadj = unadjusted odds ratio
Variable ORunadj ORadj 95% CI P value
Total hip arthroplasty 1.6 1.4 1.1 to 1.9 0.02
Age (yr) 0.99 1.0 1.0 to 1.0 0.85
Dose of intrathecal long-acting
local anesthetic
1.5 1.2 0.94 to 1.4 0.17
Type of anesthetic by gender
Male
General anesthesia only 1.0 1.0 -
Spinal anesthesia without
intrathecal morphine
1.5 1.6 0.71 to 3.6 0.26
B100 lg intrathecal morphine 6.5 7.1 3.6 to 14.0 \0.001
101–150 lg 8.6 9.3 4.2 to 20.1 \0.001
[150 lg 11.6 12.2 4.3 to 34.5 \0.001
Female
General anesthesia only 1.0 1.0 -
Spinal anesthesia without
intrathecal morphine
1.3 1.3 0.59 to 2.9 0.51
B100 lg intrathecal morphine 1.7 1.7 0.84 to 3.3 0.14
101–150 lg 2.8 2.6 1.2 to 5.8 0.02
[150 lg 1.5 1.4 0.53 to 3.6 0.51
Fig. 2 Odds ratios of urinary
retention by dose of intrathecal
morphine and gender
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123unmeasured and residual confounding are potential sources
of bias in this study. The fast-track nature of the OASIS
Program meant that patients at the CSI were relatively
young healthy subjects with few comorbid conditions
compared with subjects in prior studies.
6–10 As a result,
there may be some selection bias and an underestimate of
the risk of urinary retention.
The nurses were unblinded to the anesthetic agents in
this study, and there was a potential bias that nurses were
more likely to insert a bladder catheter in patients receiving
intrathecal morphine, which could overestimate the effect
of intrathecal morphine on the risk of urinary retention.
However, formal clinical pathways were used during the
study period, and the nursing policy was to avoid routine
bladder catheterization.
Several studies have found age[70 yr to be a risk factor
for postoperative urinary retention.
8,11 We did not identify
age as a risk factor in our cohort. Our Centre’s upper age
limit of 80 yr may explain why age was not associated with
urinary retention in our study sample. Furthermore, any
inference of age must be interpreted with caution as the
interquartile range was 55-70 yr.
Prior studies have identiﬁed obstructive urological symp-
toms to be associated with postoperative urinary retention
following major lower joint arthroplasty.
2 Although we
excluded patients with a history of chronic urinary retention,
wedidnotexcludepatientswithbenignprostatichypertrophy.
Unlike prospective studies evaluating preoperative urinary
tract or prostate symptoms,
7,8,12 we could not determine a
historyofobstructiveurologicalsymptomswithaccuracydue
to our reliance on existing records; thus, we did not examine
preoperative urological symptoms as a variable in our study.
Compared with women, the increased risk of postoperative
urinaryretentionamongstmenreceivingintrathecalmorphine
may be related to prostate symptoms.
Similarly, perioperative ﬂuid administration may play a
role in the development of postoperative urinary retention
by overdistension of the bladder.
2 As we were unable to
abstract accurate data from the patients’ medical records
regarding the volume of ﬂuids administered, we did not
examine the perioperative ﬂuid administration as a variable
in our study.
In a very recent cohort study, Hansen et al. found lack of
preoperative voiding to be associated with postoperative
urinary retention (OR 4.20; 95% CI 2.46 to 7.16).
13 Unfor-
tunately,wedidnotcollectthisinformationinourstudy,and
we can neither corroborate nor refute this association.
In spite of potential biases, our study has several
strengths. The anesthetic, surgical, and nursing practices at
the CSI were very uniform to maximize efﬁciency and
patient ﬂow from hospital admission to hospital discharge.
The high volume of the two surgical procedures allowed us
to achieve a large sample size in this study.
Our results are generalizable to orthopedic centres that
have large volumes of reasonably healthy patients under-
goingmajorlowerlimbjointarthroplasty.Theresultsmaybe
applicable to older sicker patients undergoing the same
procedure but are likely to be an underestimate of the true
risk.
Since dissemination of our results within our own cen-
tre, we have implemented bladder ultrasonography in the
recovery room for earlier diagnosis of this common com-
plication. Even though urinary retention is associated with
an increased risk of urinary tract infections and subsequent
prosthetic infection, the use of prophylactic indwelling
bladder catheters is still debatable as indwelling catheters
also increase the risk of urinary tract infections.
2 Voiding
immediately prior to surgery, early diagnosis of urinary
retention, and intermittent catheterization may be the best
approach.
2,13–16 Based on our results, individuals who are
undergoing total hip arthroplasty or are male will be at an
increased risk. For men, this risk is increased in the pres-
ence of intrathecal morphine.
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